(19)
(11) EP 4 815 964 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898737.2

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/7105(2006.01)
A61K 38/46(2006.01)
C12N 15/11(2006.01)
C12N 9/22(2006.01)
A61K 31/711(2006.01)
A61K 48/00(2006.01)
C12N 15/86(2006.01)
C12N 9/78(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 2750/14143; C12N 15/86; C12N 15/113; C12N 2310/121; C12N 15/111; C12N 2310/20
(86) International application number:
PCT/US2024/057689
(87) International publication number:
WO 2025/117698 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605049 P

(71) Applicants:
  • Massachusetts Institute of Technology
    Cambridge, MA 02139-4301 (US)
  • The Brigham & Women's Hospital, Inc.
    Boston, Massachusetts 02115 (US)
  • Beth Israel Deaconess Medical Center
    Boston, MA 02215 (US)

(72) Inventors:
  • ABUDAYYEH, Omar
    Cambridge, MA 02141 (US)
  • GOOTENBERG, Jonathan
    Cambridge, MA 02139 (US)
  • SCHMITT-ULMS, Cian
    Cambridge, MA 02139 (US)
  • KAYABOLEN, Alisan
    Cambridge, MA 02139 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) RIBOZYME-ENHANCED RNA TRANS-SPLICING